Home
>
US Stocks
>
Turning Point Therapeutics Inc
Turning Point Therapeutics Inc
TPTX

Turning Point Therapeutics Inc

$46.8937.87%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
50.16
Today Low/High
46.68 / 50.27
52 Week Low/High
$58.98 / $141.3
Market Cap
$3.26B

Company Details

Turning Point Therapeutics is a clinical-stage precision oncology company with a pipeline of internally discovered investigational drugs designed to address key limitations of existing cancer therapies. The company's lead drug candidate, repotrectinib, is a next-generation kinase inhibitor targeting the ROS1 and TRK oncogenic drivers of non-small cell lung cancer and advanced solid tumors. Repotrectinib, which is being studied in a registrational Phase 2 study in adults and a Phase 1/2 study in pediatric patients, has shown antitumor activity and durable responses among kinase inhibitor treatment-naïve and pre-treated patients. The company's pipeline of drug candidates also includes TPX-0022, targeting MET, CSF1R and SRC, which is being studied in a Phase 1 trial of patients with advanced or metastatic solid tumors harboring genetic alterations in MET; TPX-0046, targeting RET, which is being studied in a Phase 1/2 trial of patients with advanced or metastatic solid tumors harboring genetic alterations in RET; and TPX-0131, a next-generation ALK inhibitor currently pending IND submission. Turning Point's next-generation kinase inhibitors are designed to bind to their targets with greater precision and affinity than existing therapies, with a novel, compact structure that has demonstrated an ability to potentially overcome treatment resistance common with other kinase inhibitors. The company is driven to develop therapies that mark a turning point for patients in their cancer treatment.
Organisation
Turning Point Therapeutics Inc
Employees
142
Industry
Biotechnology

Discover more

Frequently Asked Questions

What is Turning Point Therapeutics Inc share price today

Can Indians buy Turning Point Therapeutics Inc shares?

How can I buy Turning Point Therapeutics Inc shares from India?

Can Fractional shares of Turning Point Therapeutics Inc be purchased?

What are the documents required to start investing in Turning Point Therapeutics Inc stocks?

We are a SEBI registered investement advisor